Terms: = Liver cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
74 results:
1. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract] [Full Text] [Related]
2. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
Feng C; Li Y; Tai Y; Zhang W; Wang H; Lian S; Jin-Si-Han EE; Liu Y; Li X; Chen Q; He M; Lu Z
Sci Rep; 2023 Nov; 13(1):19297. PubMed ID: 37935721
[TBL] [Abstract] [Full Text] [Related]
3. Insight of a lipid metabolism prognostic model to identify immune landscape and potential target for retroperitoneal liposarcoma.
Wang Z; Tao P; Fan P; Wang J; Rong T; Hou Y; Zhou Y; Lu W; Hong L; Ma L; Zhang Y; Tong H
Front Immunol; 2023; 14():1209396. PubMed ID: 37483592
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of laparoscopic liver resection for hepatocellular carcinoma in segment 8: a propensity score-matched two-center study.
Yamasaki N; Gon H; Yamane H; Yoshida T; Soyama H; Kido M; Tanaka M; Komatsu S; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
Surg Endosc; 2023 Nov; 37(11):8438-8446. PubMed ID: 37464067
[TBL] [Abstract] [Full Text] [Related]
5. The prognosis of elderly patients with hepatocellular carcinoma after curative hepatectomy a multicenter competing risk analysis.
Lu Y; Liang L; Lu WF; Cheng J; Yao WF; Xie YM; Wang DD; Xu FQ; Xiao ZQ; Zhang JG; Liu JW; Zhang CW; Huang DS
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102147. PubMed ID: 37245639
[TBL] [Abstract] [Full Text] [Related]
6. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic values of tissue-resident CD8
Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
[TBL] [Abstract] [Full Text] [Related]
8. C1orf109 promotes malignant phenotype of liver cancer via wnt signaling pathway in a CK2-dependent manner.
Sun J; Zhang X; Sun Y
J Mol Histol; 2023 Apr; 54(2):135-145. PubMed ID: 36988773
[TBL] [Abstract] [Full Text] [Related]
9. Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis.
Wang XH; Liu CJ; Wen HQ; Duan XH; Jiao YQ; Liu YJ; Chen MS; Zhu KS; Mao XH; Zhou QF
Clin Transl Med; 2023 Mar; 13(3):e1214. PubMed ID: 36855781
[TBL] [Abstract] [Full Text] [Related]
10. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative tumor abnormal protein is a promising biomarker for predicting hepatocellular carcinoma oncological outcome following curative resection.
Cai H; Li W; Zhang Y; Hua X
J Cancer Res Ther; 2022 Dec; 18(7):2021-2026. PubMed ID: 36647965
[TBL] [Abstract] [Full Text] [Related]
12. KRTCAP2 as an immunological and prognostic biomarker of hepatocellular carcinoma.
Sun P; Zhang H; Shi J; Xu M; Cheng T; Lu B; Yang L; Zhang X; Huang J
Colloids Surf B Biointerfaces; 2023 Feb; 222():113124. PubMed ID: 36634487
[TBL] [Abstract] [Full Text] [Related]
13. Seven centimeters as an optimal cutoff value for prognosis stratification in large monofocal hepatocellular carcinoma.
Yen YH; Li WF; Kee KM; Wang CC; Cheng YF; Lu SN; Hung CH; Liu YW; Hu TH
Langenbecks Arch Surg; 2023 Jan; 408(1):12. PubMed ID: 36609929
[TBL] [Abstract] [Full Text] [Related]
14. Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis.
Tian BW; Yan LJ; Ding ZN; Liu H; Meng GX; Xue JS; Han CL; Dong ZR; Hong JG; Chen ZQ; Wang DX; Li T
Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):73-83. PubMed ID: 36476076
[TBL] [Abstract] [Full Text] [Related]
15. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
[TBL] [Abstract] [Full Text] [Related]
16. Long-term Outcomes and Prognostic Factors of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.
Nagata K; Sasaki R; Iwatsu S; Fukushima M; Haraguchi M; Yamamichi S; Miuma S; Miyaaki H; Taura N; Yamazaki T; Nakao K
Anticancer Res; 2022 Oct; 42(10):5001-5007. PubMed ID: 36192013
[TBL] [Abstract] [Full Text] [Related]
17. Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States.
Lee YT; Singal AG; Lauzon M; Agopian VG; Luu M; Noureddin M; Todo T; Kim IK; Friedman ML; Kosari K; Nissen NN; Roberts LR; Heimbach JK; Gores GJ; Yang JD
Cancer; 2022 Oct; 128(20):3610-3619. PubMed ID: 35997126
[TBL] [Abstract] [Full Text] [Related]
18. C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of Foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
Kanno H; Hisaka T; Akiba J; Hashimoto K; Fujita F; Akagi Y
BMC Cancer; 2022 Aug; 22(1):839. PubMed ID: 35915403
[TBL] [Abstract] [Full Text] [Related]
19. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
[No Abstract] [Full Text] [Related]
20. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
[TBL] [Abstract] [Full Text] [Related]
[Next]
